GL1X · GenesisL1 explorer

MolNFT v1 · #16051 · protein

Influenza virus neuraminidase subtype N9 (tern) complexed with 4- guanidino-NEU5AC2EN inhibitor

1NNC · Neuraminidase N9: “Influenza virus neuraminidase subtype N9 (tern) complexed with 4- guanidino-NEU5AC2EN inhibitor”. X-ray diffraction, 5 ligands (ZMR, NAG, MAN), 2 pockets (best druggability 0.61). MolNFT v1 #16051 on GenesisL1: 3D…

PDB
1NNC
Type
protein
Length
388 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Neuraminidase N9
EC
3.2.1.18
UniProt
P03472
Ligands
ZMR, NAG, MAN, BMA, CA
Pockets
2 · best druggability 0.61

Structure

x-ray diffraction · 1 distinct chain · 3% helix, 44% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANeuraminidase N9 (EC 3.2.1.18)protein3883% helix, 44% strandP03472

Ligands and binding sites

  • ZMR · Zanamivir · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains A
  • MAN · alpha-D-mannopyranose · sugar · 4 copies
  • BMA · beta-D-mannopyranose · sugar
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13010.610.7947ZMR
2500.290.7619empty

Modifications

Observed in the structure: 9 disulfide, 3 glycan (disulfide, N-glycosylation).

Compared structures

  • 1NNC · Influenza virus neuraminidase subtype N9 (tern) complexed with 4-guanidino-NEU5AC2EN… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.